Ulcerative Colitis

Corticosteroids plus 5-aminosalicylic acid did not benefit patients with acute, severe ulcerative colitis compared with corticosteroids alone, according to a presenter at the Crohn’s and Colitis Congress.

Patients with inflammatory bowel disease reported improvement in symptoms using a personalized specific carbohydrate diet, according to a presenter at the Crohn’s and Colitis Congress.

Despite the considerable progress made in the care of inflammatory bowel disease, current therapies are “still plateauing” in terms of response and remission, according to the keynote speaker at the Crohn’s and Colitis Congress.

Although the rate of surgery for inflammatory bowel disease has declined significantly in the era of biologic therapy, “it is still occurring,” according to a presenter at the Crohn’s and Colitis Congress.

A presenter at the Crohn’s and Colitis Congress discussed the latest research on COVID-19 in patients with inflammatory bowel disease.

It is important for health care providers to ask patients with inflammatory bowel disease about sexual dysfunction and other reproductive concerns, according to a presentation at the Crohn’s and Colitis Congress.

Patients with rheumatoid arthritis, but not psoriatic arthritis or ulcerative colitis, are at a greater risk for severe or critical COVID-19 versus those with COVID-19 alone, according to data published in The Journal of Rheumatology.

In older patients with inflammatory bowel disease, adverse event rates were comparable between those treated with Stelara and those who received placebo, according to a recent analysis.

Patients with inflammatory bowel disease who responded to biologic therapy experienced improvement in sexual dysfunction, according to research presented at the ACG Annual Scientific Meeting.

Use of a universal nutritional screening tool may help identify patients with inflammatory bowel disease who are at high risk for malnutrition and other adverse outcomes, according to data presented at the ACG Annual Scientific Meeting.